Non-Invasive Shunt Quantification in Interatrial Communication (NISQIC)
Shunt Quantification in Atrial Septal Defect Using Inert Gas Rebreathing and Thoracic Bioimpedance: Comparison With the Gold Standard Method
Sponsor: Cardiology and Vascular Department, CHU Clermont-Ferrand
Terminated
recruitment difficulty
Other Cardiac Output trials with similar outcome
This NA trial investigates Cardiac Output and Congenital Heart Diseases and is currently terminated or withdrawn. Cardiology and Vascular Department, CHU Clermont-Ferrand leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2022 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Oct 2021 — Nov 2022 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cardiology and Vascular Department, CHU Clermont-Ferrand
- Sport Medicine Department, CHU Clermont-Ferrand
- University Hospital, Clermont-Ferrand
For direct contact, visit the study record on ClinicalTrials.gov .